nodes	percent_of_prediction	percent_of_DWPC	metapath
Permethrin—CYP3A4—Everolimus—kidney cancer	0.173	0.223	CbGbCtD
Permethrin—CYP3A4—Temsirolimus—kidney cancer	0.117	0.15	CbGbCtD
Permethrin—CYP2B6—Sorafenib—kidney cancer	0.116	0.149	CbGbCtD
Permethrin—CYP2B6—Doxorubicin—kidney cancer	0.0704	0.0905	CbGbCtD
Permethrin—CYP3A4—Pazopanib—kidney cancer	0.0615	0.079	CbGbCtD
Permethrin—CYP3A4—Erlotinib—kidney cancer	0.0439	0.0564	CbGbCtD
Permethrin—CYP3A4—Paclitaxel—kidney cancer	0.0402	0.0516	CbGbCtD
Permethrin—CYP3A4—Sorafenib—kidney cancer	0.0357	0.0458	CbGbCtD
Permethrin—CYP3A4—Vinblastine—kidney cancer	0.0352	0.0452	CbGbCtD
Permethrin—CYP3A4—Vincristine—kidney cancer	0.0346	0.0445	CbGbCtD
Permethrin—CYP3A4—Sunitinib—kidney cancer	0.0289	0.0371	CbGbCtD
Permethrin—CYP3A4—Doxorubicin—kidney cancer	0.0216	0.0278	CbGbCtD
Permethrin—Numbness—Vinblastine—kidney cancer	0.00528	0.0269	CcSEcCtD
Permethrin—Sensory loss—Vinblastine—kidney cancer	0.00505	0.0257	CcSEcCtD
Permethrin—Numbness—Vincristine—kidney cancer	0.00371	0.0189	CcSEcCtD
Permethrin—Sensory loss—Vincristine—kidney cancer	0.00355	0.0181	CcSEcCtD
Permethrin—Tingling sensation—Paclitaxel—kidney cancer	0.00304	0.0155	CcSEcCtD
Permethrin—Sensory loss—Paclitaxel—kidney cancer	0.00282	0.0144	CcSEcCtD
Permethrin—Hypoaesthesia—Pazopanib—kidney cancer	0.00276	0.014	CcSEcCtD
Permethrin—SCN1A—Interaction between L1 and Ankyrins—SPTBN4—kidney cancer	0.00271	0.124	CbGpPWpGaD
Permethrin—SCN1A—Interaction between L1 and Ankyrins—L1CAM—kidney cancer	0.00271	0.124	CbGpPWpGaD
Permethrin—Erythema—Temsirolimus—kidney cancer	0.00256	0.013	CcSEcCtD
Permethrin—Tingling sensation—Capecitabine—kidney cancer	0.0025	0.0127	CcSEcCtD
Permethrin—Erythema—Pazopanib—kidney cancer	0.00241	0.0123	CcSEcCtD
Permethrin—Hypoaesthesia—Vinblastine—kidney cancer	0.00219	0.0111	CcSEcCtD
Permethrin—Fenoprofen—PTGS1—kidney cancer	0.00218	0.636	CrCbGaD
Permethrin—Hypoaesthesia—Everolimus—kidney cancer	0.00218	0.0111	CcSEcCtD
Permethrin—Erythema—Everolimus—kidney cancer	0.00191	0.0097	CcSEcCtD
Permethrin—Erythema—Erlotinib—kidney cancer	0.00184	0.00936	CcSEcCtD
Permethrin—Hypoaesthesia—Sunitinib—kidney cancer	0.00182	0.00926	CcSEcCtD
Permethrin—Pain—Temsirolimus—kidney cancer	0.00179	0.0091	CcSEcCtD
Permethrin—Paraesthesia—Pazopanib—kidney cancer	0.00177	0.009	CcSEcCtD
Permethrin—Gastrointestinal pain—Temsirolimus—kidney cancer	0.00171	0.0087	CcSEcCtD
Permethrin—Pain—Pazopanib—kidney cancer	0.00168	0.00857	CcSEcCtD
Permethrin—Erythema—Sorafenib—kidney cancer	0.00165	0.00842	CcSEcCtD
Permethrin—Body temperature increased—Temsirolimus—kidney cancer	0.00165	0.00841	CcSEcCtD
Permethrin—Abdominal pain—Temsirolimus—kidney cancer	0.00165	0.00841	CcSEcCtD
Permethrin—Gastrointestinal pain—Pazopanib—kidney cancer	0.00161	0.0082	CcSEcCtD
Permethrin—Stinging—Doxorubicin—kidney cancer	0.0016	0.00813	CcSEcCtD
Permethrin—Erythema—Sunitinib—kidney cancer	0.00159	0.0081	CcSEcCtD
Permethrin—Abdominal pain—Pazopanib—kidney cancer	0.00156	0.00792	CcSEcCtD
Permethrin—Hypoaesthesia—Vincristine—kidney cancer	0.00154	0.00783	CcSEcCtD
Permethrin—Erythema—Dactinomycin—kidney cancer	0.00151	0.00767	CcSEcCtD
Permethrin—Pruritus—Temsirolimus—kidney cancer	0.00148	0.00753	CcSEcCtD
Permethrin—Diarrhoea—Temsirolimus—kidney cancer	0.00143	0.00728	CcSEcCtD
Permethrin—Paraesthesia—Vinblastine—kidney cancer	0.0014	0.00713	CcSEcCtD
Permethrin—Paraesthesia—Everolimus—kidney cancer	0.0014	0.00711	CcSEcCtD
Permethrin—Pruritus—Pazopanib—kidney cancer	0.00139	0.00709	CcSEcCtD
Permethrin—Dizziness—Temsirolimus—kidney cancer	0.00138	0.00704	CcSEcCtD
Permethrin—Diarrhoea—Pazopanib—kidney cancer	0.00135	0.00686	CcSEcCtD
Permethrin—Pain—Vinblastine—kidney cancer	0.00133	0.00679	CcSEcCtD
Permethrin—Pain—Everolimus—kidney cancer	0.00133	0.00677	CcSEcCtD
Permethrin—Vomiting—Temsirolimus—kidney cancer	0.00133	0.00676	CcSEcCtD
Permethrin—Rash—Temsirolimus—kidney cancer	0.00132	0.00671	CcSEcCtD
Permethrin—Dermatitis—Temsirolimus—kidney cancer	0.00132	0.0067	CcSEcCtD
Permethrin—Headache—Temsirolimus—kidney cancer	0.00131	0.00667	CcSEcCtD
Permethrin—Dizziness—Pazopanib—kidney cancer	0.0013	0.00663	CcSEcCtD
Permethrin—Pain—Erlotinib—kidney cancer	0.00128	0.00653	CcSEcCtD
Permethrin—Erythema—Gemcitabine—kidney cancer	0.00128	0.0065	CcSEcCtD
Permethrin—Gastrointestinal pain—Vinblastine—kidney cancer	0.00128	0.0065	CcSEcCtD
Permethrin—Gastrointestinal pain—Everolimus—kidney cancer	0.00127	0.00647	CcSEcCtD
Permethrin—Vomiting—Pazopanib—kidney cancer	0.00125	0.00637	CcSEcCtD
Permethrin—Fenoprofen—PTGS2—kidney cancer	0.00125	0.364	CrCbGaD
Permethrin—Rash—Pazopanib—kidney cancer	0.00124	0.00632	CcSEcCtD
Permethrin—Nausea—Temsirolimus—kidney cancer	0.00124	0.00632	CcSEcCtD
Permethrin—Dermatitis—Pazopanib—kidney cancer	0.00124	0.00631	CcSEcCtD
Permethrin—Abdominal pain—Vinblastine—kidney cancer	0.00123	0.00628	CcSEcCtD
Permethrin—Headache—Pazopanib—kidney cancer	0.00123	0.00628	CcSEcCtD
Permethrin—Abdominal pain—Everolimus—kidney cancer	0.00123	0.00626	CcSEcCtD
Permethrin—Body temperature increased—Everolimus—kidney cancer	0.00123	0.00626	CcSEcCtD
Permethrin—Gastrointestinal pain—Erlotinib—kidney cancer	0.00123	0.00624	CcSEcCtD
Permethrin—Hypoaesthesia—Paclitaxel—kidney cancer	0.00122	0.00622	CcSEcCtD
Permethrin—Abdominal pain—Erlotinib—kidney cancer	0.00119	0.00604	CcSEcCtD
Permethrin—Body temperature increased—Erlotinib—kidney cancer	0.00119	0.00604	CcSEcCtD
Permethrin—Nausea—Pazopanib—kidney cancer	0.00117	0.00595	CcSEcCtD
Permethrin—Paraesthesia—Sunitinib—kidney cancer	0.00117	0.00594	CcSEcCtD
Permethrin—Pain—Sorafenib—kidney cancer	0.00115	0.00587	CcSEcCtD
Permethrin—Pain—Sunitinib—kidney cancer	0.00111	0.00565	CcSEcCtD
Permethrin—Gastrointestinal pain—Sorafenib—kidney cancer	0.0011	0.00562	CcSEcCtD
Permethrin—Pruritus—Everolimus—kidney cancer	0.0011	0.0056	CcSEcCtD
Permethrin—Erythema—Paclitaxel—kidney cancer	0.00107	0.00544	CcSEcCtD
Permethrin—Diarrhoea—Vinblastine—kidney cancer	0.00107	0.00544	CcSEcCtD
Permethrin—Abdominal pain—Sorafenib—kidney cancer	0.00107	0.00543	CcSEcCtD
Permethrin—Body temperature increased—Sorafenib—kidney cancer	0.00107	0.00543	CcSEcCtD
Permethrin—Diarrhoea—Everolimus—kidney cancer	0.00106	0.00542	CcSEcCtD
Permethrin—Gastrointestinal pain—Sunitinib—kidney cancer	0.00106	0.00541	CcSEcCtD
Permethrin—Pruritus—Erlotinib—kidney cancer	0.00106	0.0054	CcSEcCtD
Permethrin—Pain—Dactinomycin—kidney cancer	0.00105	0.00535	CcSEcCtD
Permethrin—SCN1A—L1CAM interactions—L1CAM—kidney cancer	0.00104	0.0478	CbGpPWpGaD
Permethrin—SCN1A—L1CAM interactions—SPTBN4—kidney cancer	0.00104	0.0478	CbGpPWpGaD
Permethrin—Dizziness—Vinblastine—kidney cancer	0.00103	0.00525	CcSEcCtD
Permethrin—Dizziness—Everolimus—kidney cancer	0.00103	0.00523	CcSEcCtD
Permethrin—Abdominal pain—Sunitinib—kidney cancer	0.00103	0.00523	CcSEcCtD
Permethrin—Body temperature increased—Sunitinib—kidney cancer	0.00103	0.00523	CcSEcCtD
Permethrin—Diarrhoea—Erlotinib—kidney cancer	0.00103	0.00522	CcSEcCtD
Permethrin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00101	0.00512	CcSEcCtD
Permethrin—Hypoaesthesia—Capecitabine—kidney cancer	0.001	0.0051	CcSEcCtD
Permethrin—Vomiting—Vinblastine—kidney cancer	0.000992	0.00505	CcSEcCtD
Permethrin—Dizziness—Erlotinib—kidney cancer	0.000992	0.00505	CcSEcCtD
Permethrin—Vomiting—Everolimus—kidney cancer	0.000989	0.00503	CcSEcCtD
Permethrin—Paraesthesia—Vincristine—kidney cancer	0.000986	0.00502	CcSEcCtD
Permethrin—Rash—Everolimus—kidney cancer	0.00098	0.00499	CcSEcCtD
Permethrin—Dermatitis—Everolimus—kidney cancer	0.000979	0.00499	CcSEcCtD
Permethrin—Headache—Vinblastine—kidney cancer	0.000978	0.00498	CcSEcCtD
Permethrin—Headache—Everolimus—kidney cancer	0.000974	0.00496	CcSEcCtD
Permethrin—Abdominal pain—Dactinomycin—kidney cancer	0.000972	0.00495	CcSEcCtD
Permethrin—Body temperature increased—Dactinomycin—kidney cancer	0.000972	0.00495	CcSEcCtD
Permethrin—Pruritus—Sorafenib—kidney cancer	0.000955	0.00486	CcSEcCtD
Permethrin—Vomiting—Erlotinib—kidney cancer	0.000954	0.00486	CcSEcCtD
Permethrin—Rash—Erlotinib—kidney cancer	0.000946	0.00481	CcSEcCtD
Permethrin—Dermatitis—Erlotinib—kidney cancer	0.000945	0.00481	CcSEcCtD
Permethrin—Headache—Erlotinib—kidney cancer	0.00094	0.00478	CcSEcCtD
Permethrin—Pain—Vincristine—kidney cancer	0.000939	0.00478	CcSEcCtD
Permethrin—Paraesthesia—Gemcitabine—kidney cancer	0.000936	0.00476	CcSEcCtD
Permethrin—Nausea—Vinblastine—kidney cancer	0.000927	0.00472	CcSEcCtD
Permethrin—Nausea—Everolimus—kidney cancer	0.000924	0.0047	CcSEcCtD
Permethrin—Diarrhoea—Sorafenib—kidney cancer	0.000923	0.0047	CcSEcCtD
Permethrin—Pruritus—Sunitinib—kidney cancer	0.000919	0.00468	CcSEcCtD
Permethrin—Gastrointestinal pain—Vincristine—kidney cancer	0.000898	0.00457	CcSEcCtD
Permethrin—Dizziness—Sorafenib—kidney cancer	0.000893	0.00454	CcSEcCtD
Permethrin—Pain—Gemcitabine—kidney cancer	0.000891	0.00454	CcSEcCtD
Permethrin—Nausea—Erlotinib—kidney cancer	0.000891	0.00454	CcSEcCtD
Permethrin—Diarrhoea—Sunitinib—kidney cancer	0.000889	0.00452	CcSEcCtD
Permethrin—Erythema—Capecitabine—kidney cancer	0.000877	0.00447	CcSEcCtD
Permethrin—Body temperature increased—Vincristine—kidney cancer	0.000868	0.00442	CcSEcCtD
Permethrin—Abdominal pain—Vincristine—kidney cancer	0.000868	0.00442	CcSEcCtD
Permethrin—Dizziness—Sunitinib—kidney cancer	0.000859	0.00437	CcSEcCtD
Permethrin—Vomiting—Sorafenib—kidney cancer	0.000858	0.00437	CcSEcCtD
Permethrin—Rash—Sorafenib—kidney cancer	0.000851	0.00433	CcSEcCtD
Permethrin—Dermatitis—Sorafenib—kidney cancer	0.00085	0.00433	CcSEcCtD
Permethrin—Headache—Sorafenib—kidney cancer	0.000846	0.0043	CcSEcCtD
Permethrin—Diarrhoea—Dactinomycin—kidney cancer	0.000841	0.00428	CcSEcCtD
Permethrin—Vomiting—Sunitinib—kidney cancer	0.000826	0.0042	CcSEcCtD
Permethrin—Body temperature increased—Gemcitabine—kidney cancer	0.000824	0.00419	CcSEcCtD
Permethrin—Rash—Sunitinib—kidney cancer	0.000819	0.00417	CcSEcCtD
Permethrin—Dermatitis—Sunitinib—kidney cancer	0.000818	0.00416	CcSEcCtD
Permethrin—Headache—Sunitinib—kidney cancer	0.000814	0.00414	CcSEcCtD
Permethrin—Nausea—Sorafenib—kidney cancer	0.000802	0.00408	CcSEcCtD
Permethrin—CYP3A4—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.000785	0.036	CbGpPWpGaD
Permethrin—Paraesthesia—Paclitaxel—kidney cancer	0.000783	0.00399	CcSEcCtD
Permethrin—Vomiting—Dactinomycin—kidney cancer	0.000782	0.00398	CcSEcCtD
Permethrin—Rash—Dactinomycin—kidney cancer	0.000775	0.00395	CcSEcCtD
Permethrin—Nausea—Sunitinib—kidney cancer	0.000771	0.00393	CcSEcCtD
Permethrin—Diarrhoea—Vincristine—kidney cancer	0.000752	0.00383	CcSEcCtD
Permethrin—Pain—Paclitaxel—kidney cancer	0.000746	0.0038	CcSEcCtD
Permethrin—Pruritus—Gemcitabine—kidney cancer	0.000737	0.00375	CcSEcCtD
Permethrin—Nausea—Dactinomycin—kidney cancer	0.00073	0.00372	CcSEcCtD
Permethrin—Dizziness—Vincristine—kidney cancer	0.000726	0.0037	CcSEcCtD
Permethrin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000713	0.00363	CcSEcCtD
Permethrin—Diarrhoea—Gemcitabine—kidney cancer	0.000713	0.00363	CcSEcCtD
Permethrin—Vomiting—Vincristine—kidney cancer	0.000698	0.00356	CcSEcCtD
Permethrin—Rash—Vincristine—kidney cancer	0.000693	0.00353	CcSEcCtD
Permethrin—Dermatitis—Vincristine—kidney cancer	0.000692	0.00352	CcSEcCtD
Permethrin—Abdominal pain—Paclitaxel—kidney cancer	0.00069	0.00351	CcSEcCtD
Permethrin—Body temperature increased—Paclitaxel—kidney cancer	0.00069	0.00351	CcSEcCtD
Permethrin—Headache—Vincristine—kidney cancer	0.000688	0.0035	CcSEcCtD
Permethrin—Vomiting—Gemcitabine—kidney cancer	0.000663	0.00337	CcSEcCtD
Permethrin—Rash—Gemcitabine—kidney cancer	0.000657	0.00334	CcSEcCtD
Permethrin—Dermatitis—Gemcitabine—kidney cancer	0.000656	0.00334	CcSEcCtD
Permethrin—Headache—Gemcitabine—kidney cancer	0.000653	0.00332	CcSEcCtD
Permethrin—Nausea—Vincristine—kidney cancer	0.000652	0.00332	CcSEcCtD
Permethrin—Hypoaesthesia—Doxorubicin—kidney cancer	0.000646	0.00329	CcSEcCtD
Permethrin—Paraesthesia—Capecitabine—kidney cancer	0.000643	0.00327	CcSEcCtD
Permethrin—Nausea—Gemcitabine—kidney cancer	0.000619	0.00315	CcSEcCtD
Permethrin—Pruritus—Paclitaxel—kidney cancer	0.000617	0.00314	CcSEcCtD
Permethrin—Pain—Capecitabine—kidney cancer	0.000612	0.00312	CcSEcCtD
Permethrin—Diarrhoea—Paclitaxel—kidney cancer	0.000597	0.00304	CcSEcCtD
Permethrin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000585	0.00298	CcSEcCtD
Permethrin—Dizziness—Paclitaxel—kidney cancer	0.000577	0.00294	CcSEcCtD
Permethrin—Body temperature increased—Capecitabine—kidney cancer	0.000566	0.00288	CcSEcCtD
Permethrin—Abdominal pain—Capecitabine—kidney cancer	0.000566	0.00288	CcSEcCtD
Permethrin—Erythema—Doxorubicin—kidney cancer	0.000566	0.00288	CcSEcCtD
Permethrin—Vomiting—Paclitaxel—kidney cancer	0.000555	0.00282	CcSEcCtD
Permethrin—Rash—Paclitaxel—kidney cancer	0.00055	0.0028	CcSEcCtD
Permethrin—Dermatitis—Paclitaxel—kidney cancer	0.00055	0.0028	CcSEcCtD
Permethrin—Headache—Paclitaxel—kidney cancer	0.000547	0.00278	CcSEcCtD
Permethrin—SCN1A—Axon guidance—UNC5C—kidney cancer	0.000519	0.0238	CbGpPWpGaD
Permethrin—Nausea—Paclitaxel—kidney cancer	0.000518	0.00264	CcSEcCtD
Permethrin—Pruritus—Capecitabine—kidney cancer	0.000507	0.00258	CcSEcCtD
Permethrin—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000493	0.0227	CbGpPWpGaD
Permethrin—Diarrhoea—Capecitabine—kidney cancer	0.00049	0.00249	CcSEcCtD
Permethrin—Dizziness—Capecitabine—kidney cancer	0.000473	0.00241	CcSEcCtD
Permethrin—Vomiting—Capecitabine—kidney cancer	0.000455	0.00232	CcSEcCtD
Permethrin—Rash—Capecitabine—kidney cancer	0.000451	0.0023	CcSEcCtD
Permethrin—Dermatitis—Capecitabine—kidney cancer	0.000451	0.0023	CcSEcCtD
Permethrin—Headache—Capecitabine—kidney cancer	0.000449	0.00228	CcSEcCtD
Permethrin—Nausea—Capecitabine—kidney cancer	0.000425	0.00216	CcSEcCtD
Permethrin—Paraesthesia—Doxorubicin—kidney cancer	0.000414	0.00211	CcSEcCtD
Permethrin—SCN1A—L1CAM interactions—PAK1—kidney cancer	0.000398	0.0183	CbGpPWpGaD
Permethrin—Pain—Doxorubicin—kidney cancer	0.000395	0.00201	CcSEcCtD
Permethrin—SCN1A—Axon guidance—L1CAM—kidney cancer	0.000393	0.018	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—SPTBN4—kidney cancer	0.000393	0.018	CbGpPWpGaD
Permethrin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000377	0.00192	CcSEcCtD
Permethrin—SCN1A—Developmental Biology—UNC5C—kidney cancer	0.00037	0.017	CbGpPWpGaD
Permethrin—Abdominal pain—Doxorubicin—kidney cancer	0.000365	0.00186	CcSEcCtD
Permethrin—Body temperature increased—Doxorubicin—kidney cancer	0.000365	0.00186	CcSEcCtD
Permethrin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—kidney cancer	0.000358	0.0164	CbGpPWpGaD
Permethrin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000331	0.0152	CbGpPWpGaD
Permethrin—Pruritus—Doxorubicin—kidney cancer	0.000327	0.00166	CcSEcCtD
Permethrin—CYP2B6—Xenobiotics—CYP1A1—kidney cancer	0.000322	0.0148	CbGpPWpGaD
Permethrin—Diarrhoea—Doxorubicin—kidney cancer	0.000316	0.00161	CcSEcCtD
Permethrin—CYP2B6—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000306	0.014	CbGpPWpGaD
Permethrin—Dizziness—Doxorubicin—kidney cancer	0.000305	0.00155	CcSEcCtD
Permethrin—CYP2B6—Biological oxidations—ACY1—kidney cancer	0.000296	0.0136	CbGpPWpGaD
Permethrin—Vomiting—Doxorubicin—kidney cancer	0.000293	0.00149	CcSEcCtD
Permethrin—Rash—Doxorubicin—kidney cancer	0.000291	0.00148	CcSEcCtD
Permethrin—Dermatitis—Doxorubicin—kidney cancer	0.000291	0.00148	CcSEcCtD
Permethrin—Headache—Doxorubicin—kidney cancer	0.000289	0.00147	CcSEcCtD
Permethrin—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	0.000281	0.0129	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—L1CAM—kidney cancer	0.00028	0.0129	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—SPTBN4—kidney cancer	0.00028	0.0129	CbGpPWpGaD
Permethrin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	0.000277	0.0127	CbGpPWpGaD
Permethrin—Nausea—Doxorubicin—kidney cancer	0.000274	0.0014	CcSEcCtD
Permethrin—SCN1A—Developmental Biology—CER1—kidney cancer	0.000245	0.0113	CbGpPWpGaD
Permethrin—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.00024	0.011	CbGpPWpGaD
Permethrin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000229	0.0105	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—HNF1A—kidney cancer	0.000222	0.0102	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—EPAS1—kidney cancer	0.000222	0.0102	CbGpPWpGaD
Permethrin—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000212	0.00973	CbGpPWpGaD
Permethrin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000181	0.00832	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—HNF1B—kidney cancer	0.000181	0.0083	CbGpPWpGaD
Permethrin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000175	0.00804	CbGpPWpGaD
Permethrin—CYP2B6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000168	0.00773	CbGpPWpGaD
Permethrin—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.000168	0.00772	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—ALDH1A1—kidney cancer	0.000162	0.00746	CbGpPWpGaD
Permethrin—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.000159	0.00732	CbGpPWpGaD
Permethrin—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000153	0.00701	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—PAK1—kidney cancer	0.000151	0.00692	CbGpPWpGaD
Permethrin—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	0.000146	0.00672	CbGpPWpGaD
Permethrin—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000141	0.00647	CbGpPWpGaD
Permethrin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000139	0.00638	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—ACY1—kidney cancer	0.000135	0.00618	CbGpPWpGaD
Permethrin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000134	0.00614	CbGpPWpGaD
Permethrin—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000132	0.00606	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—CTNNA1—kidney cancer	0.000129	0.00595	CbGpPWpGaD
Permethrin—SCN1A—L1CAM interactions—MAPK3—kidney cancer	0.000129	0.00594	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—PAX6—kidney cancer	0.000124	0.00569	CbGpPWpGaD
Permethrin—SCN1A—L1CAM interactions—MAPK1—kidney cancer	0.000123	0.00565	CbGpPWpGaD
Permethrin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000109	0.00502	CbGpPWpGaD
Permethrin—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000108	0.00498	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—PAK1—kidney cancer	0.000107	0.00493	CbGpPWpGaD
Permethrin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000104	0.00478	CbGpPWpGaD
Permethrin—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	9.98e-05	0.00458	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GSTT1—kidney cancer	9.54e-05	0.00438	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—KDR—kidney cancer	9.37e-05	0.0043	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—MET—kidney cancer	9.17e-05	0.00421	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—PTGS1—kidney cancer	8.94e-05	0.00411	CbGpPWpGaD
Permethrin—CYP2B6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	8.09e-05	0.00371	CbGpPWpGaD
Permethrin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	7.65e-05	0.00351	CbGpPWpGaD
Permethrin—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	7.52e-05	0.00345	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	7.38e-05	0.00339	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—RAF1—kidney cancer	6.78e-05	0.00311	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—ERBB2—kidney cancer	6.7e-05	0.00308	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—KDR—kidney cancer	6.69e-05	0.00307	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GSTP1—kidney cancer	6.61e-05	0.00304	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—MET—kidney cancer	6.54e-05	0.00301	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—GSTP1—kidney cancer	6.52e-05	0.003	CbGpPWpGaD
Permethrin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	6.08e-05	0.00279	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GSTM1—kidney cancer	6.08e-05	0.00279	CbGpPWpGaD
Permethrin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	6e-05	0.00276	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—GSTM1—kidney cancer	5.99e-05	0.00275	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—CYP1A1—kidney cancer	5.76e-05	0.00265	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—CYP1A1—kidney cancer	5.68e-05	0.00261	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—VEGFA—kidney cancer	5.16e-05	0.00237	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ACY1—kidney cancer	5.07e-05	0.00233	CbGpPWpGaD
Permethrin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	4.93e-05	0.00226	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—MAPK3—kidney cancer	4.88e-05	0.00224	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—RAF1—kidney cancer	4.84e-05	0.00222	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—RELA—kidney cancer	4.81e-05	0.00221	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—ERBB2—kidney cancer	4.78e-05	0.0022	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—MAPK1—kidney cancer	4.65e-05	0.00213	CbGpPWpGaD
Permethrin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	4.53e-05	0.00208	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—KRAS—kidney cancer	4.39e-05	0.00202	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTT1—kidney cancer	4.34e-05	0.00199	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PDHB—kidney cancer	4.31e-05	0.00198	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—POMC—kidney cancer	4.3e-05	0.00197	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—CTNNB1—kidney cancer	4.19e-05	0.00192	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—PTGS1—kidney cancer	4.06e-05	0.00187	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CCBL1—kidney cancer	4.05e-05	0.00186	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—VEGFA—kidney cancer	3.68e-05	0.00169	CbGpPWpGaD
Permethrin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.68e-05	0.00169	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PPAT—kidney cancer	3.51e-05	0.00161	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GLIPR1—kidney cancer	3.51e-05	0.00161	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—MAPK3—kidney cancer	3.49e-05	0.0016	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—MAPK1—kidney cancer	3.32e-05	0.00152	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—FH—kidney cancer	3.27e-05	0.0015	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—APRT—kidney cancer	3.27e-05	0.0015	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—KRAS—kidney cancer	3.13e-05	0.00144	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GPC3—kidney cancer	3.07e-05	0.00141	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.01e-05	0.00138	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CA2—kidney cancer	2.99e-05	0.00137	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.96e-05	0.00136	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ALAD—kidney cancer	2.91e-05	0.00134	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ST3GAL2—kidney cancer	2.84e-05	0.0013	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ALDH1A1—kidney cancer	2.78e-05	0.00128	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.76e-05	0.00127	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.72e-05	0.00125	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PGK1—kidney cancer	2.66e-05	0.00122	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—SLC5A3—kidney cancer	2.66e-05	0.00122	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.62e-05	0.0012	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—LDHB—kidney cancer	2.61e-05	0.0012	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.58e-05	0.00119	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ACY1—kidney cancer	2.3e-05	0.00106	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CA9—kidney cancer	2.26e-05	0.00104	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PDHB—kidney cancer	1.96e-05	0.000899	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—POMC—kidney cancer	1.95e-05	0.000897	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CRABP1—kidney cancer	1.92e-05	0.000884	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CCBL1—kidney cancer	1.84e-05	0.000846	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ITPR2—kidney cancer	1.79e-05	0.000822	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTT1—kidney cancer	1.63e-05	0.000749	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ACHE—kidney cancer	1.63e-05	0.000749	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PPAT—kidney cancer	1.6e-05	0.000733	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.6e-05	0.000733	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—SCARB1—kidney cancer	1.54e-05	0.000709	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PTGS1—kidney cancer	1.53e-05	0.000702	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PSMD7—kidney cancer	1.5e-05	0.000689	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—APRT—kidney cancer	1.48e-05	0.000682	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—FH—kidney cancer	1.48e-05	0.000682	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—BCHE—kidney cancer	1.42e-05	0.000653	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.4e-05	0.000645	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GPC3—kidney cancer	1.4e-05	0.000641	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CA2—kidney cancer	1.36e-05	0.000623	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.36e-05	0.000623	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ALAD—kidney cancer	1.32e-05	0.000607	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.29e-05	0.000593	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.26e-05	0.00058	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PGK1—kidney cancer	1.21e-05	0.000556	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.21e-05	0.000556	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—LDHB—kidney cancer	1.19e-05	0.000545	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTP1—kidney cancer	1.13e-05	0.000519	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ABCB1—kidney cancer	1.07e-05	0.000492	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTM1—kidney cancer	1.04e-05	0.000477	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CA9—kidney cancer	1.03e-05	0.000472	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CYP1A1—kidney cancer	9.85e-06	0.000453	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CRABP1—kidney cancer	8.75e-06	0.000402	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ITPR2—kidney cancer	8.13e-06	0.000373	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ACHE—kidney cancer	7.42e-06	0.000341	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTT1—kidney cancer	7.42e-06	0.000341	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—POMC—kidney cancer	7.35e-06	0.000337	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—SCARB1—kidney cancer	7.02e-06	0.000322	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PTGS1—kidney cancer	6.95e-06	0.000319	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PSMD7—kidney cancer	6.81e-06	0.000313	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—BCHE—kidney cancer	6.46e-06	0.000297	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—SLC5A5—kidney cancer	6.38e-06	0.000293	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—SLC2A1—kidney cancer	6.16e-06	0.000283	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PTGS2—kidney cancer	5.86e-06	0.000269	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTP1—kidney cancer	5.14e-06	0.000236	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PTEN—kidney cancer	5.11e-06	0.000235	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ABCB1—kidney cancer	4.87e-06	0.000223	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTM1—kidney cancer	4.72e-06	0.000217	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.48e-06	0.000206	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PIK3CA—kidney cancer	3.61e-06	0.000166	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—POMC—kidney cancer	3.34e-06	0.000153	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PTGS2—kidney cancer	2.66e-06	0.000122	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PTEN—kidney cancer	2.32e-06	0.000107	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.64e-06	7.52e-05	CbGpPWpGaD
